Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / HEALTHCARE BUL
-
Total 13F shares
-
234,450
-
Share change
-
-98,440
-
Total reported value
-
$11,856
-
Put/Call ratio
-
67%
-
Price per share
-
$0.05
-
Number of holders
-
17
-
Value change
-
-$5,214
-
Number of buys
-
5
-
Number of sells
-
6
Institutional Holders of DIREXION SHS ETF TR - HEALTHCARE BUL (CURE) as of Q3 2019
As of 30 Sep 2019,
DIREXION SHS ETF TR - HEALTHCARE BUL (CURE) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
234,450 shares.
The largest 10 holders included
CITADEL ADVISORS LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Tower Research Capital LLC (TRC), BANQUE PICTET & CIE SA, Virtu Financial LLC, Traynor Capital Management, Inc., Capital Analysts, LLC, XR Securities LLC, UBS Group AG, and Ellis Investment Partners, LLC.
This page lists
17
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.